Manulife (Manufacturers Life Insurance)’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$102K Buy
27,262
+2,097
+8% +$7.82K ﹤0.01% 2753
2025
Q1
$69.5K Buy
25,165
+787
+3% +$2.17K ﹤0.01% 2778
2024
Q4
$135K Sell
24,378
-41,722
-63% -$231K ﹤0.01% 2758
2024
Q3
$551K Buy
66,100
+43,455
+192% +$362K ﹤0.01% 2238
2024
Q2
$154K Buy
22,645
+5,049
+29% +$34.4K ﹤0.01% 2699
2024
Q1
$115K Sell
17,596
-2,173
-11% -$14.3K ﹤0.01% 2747
2023
Q4
$128K Buy
19,769
+2,789
+16% +$18.1K ﹤0.01% 2750
2023
Q3
$85.4K Buy
16,980
+144
+0.9% +$724 ﹤0.01% 2855
2023
Q2
$147K Buy
+16,836
New +$147K ﹤0.01% 2723